Abemaciclib for the treatment of brain metastases (BM) secondary to hormone receptor positive (HR+), HER2 negative breast cancer.Sara M. Tolaney, Carey K. Anders, Timothy M. Costigan et al.|Journal of Clinical Oncology|2017Cited by 53
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumorsRobert M. Jotte, Robert Ilaria, Daniel D. Von Hoff et al.|Investigational New Drugs|2014Cited by 10